In addition, GPR125 positively regulates osteoclasts through RANKL-stimulated MAPK and AKT-NF-κB signaling pathways to participate in the treatment of osteoporosis (Tang et al., 2022). This evidence concerns the gene NFKB1 and osteoporosis.